PharmaCyte Biotech (PMCB)
NASDAQ:PMCB
Holding PMCB?
Track your performance easily

PharmaCyte Biotech (PMCB) Financial Statements

215 Followers

PharmaCyte Biotech Financial Overview

PharmaCyte Biotech's market cap is currently ―. The company's EPS TTM is $0.674; its P/E ratio is 2.79; PharmaCyte Biotech is scheduled to report earnings on March 16, 2022, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Apr 24Jan 24Oct 23Jul 23Apr 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 1.35M$ -1.87M$ 2.79M$ -3.18M-
EBITDA$ 1.35M$ -1.87M$ 2.79M$ -3.18M-
Net Income Common Stockholders$ -5.86M$ -5.62M$ -2.26M$ -3.50M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 50.18M$ 61.21M$ 73.43M$ 74.66M$ 68.04M
Total Assets$ 59.90M$ 71.36M$ 78.88M$ 79.88M$ 73.28M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -50.18M$ -61.21M$ -73.43M$ -74.66M$ -68.04M
Total Liabilities$ 20.39M$ 22.47M$ 20.81M$ 37.15M$ 586.58K
Stockholders Equity$ 27.65M$ 31.37M$ 36.77M$ 42.73M$ 72.69M
Cash Flow-
Free Cash Flow$ -332.96K$ -177.10K$ -1.98M$ 342.96K-
Operating Cash Flow$ -332.96K$ -177.10K$ -1.98M$ 342.96K-
Investing Cash Flow-$ -5.00M---
Financing Cash Flow$ -10.70M$ -7.04M$ 748.69K$ 6.28M-
Currency in USD

PharmaCyte Biotech Earnings and Revenue History

PharmaCyte Biotech Debt to Assets

PharmaCyte Biotech Cash Flow

PharmaCyte Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis